Tislelizumab plus AG regimen for long-term CR in 2 patients with metastatic BRCA-mutation pancreatic cancer: A case report
The combination of triple therapy followed by maintenance therapy shows promise as a potential treatment option for PC patients with BRCA mutations. Further clinical investigation is needed to confirm its efficacy and safety.
Authors
- Lili Lv (ORCID: https://orcid.org/0009-0001-6538-2156)
- Xue Xu
- Feng Gao (ORCID: https://orcid.org/0000-0002-4731-3886)
- Chun‐Hong Chen (ORCID: https://orcid.org/0000-0002-5166-9017)
Institutions
- Nanfang Hospital (CN)
- Hebei General Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1097/md.0000000000040997
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00